A mechanism enabling cells to bind and isolate toxic substances could have significant implications for how tumours develop resistance to certain types of chemotherapy.
Genomics has the potential to significantly improve the efficacy of drugs and develop targeted therapies.
We’d all dearly like to see a cure for the common cold, but it never quite seems to arrive. So what’s the hold-up — and will it be over soon? Getting rid of this scourge is nothing to be sneezed at.
Computational researchers have developed a computer program which has revealed a previously unknown combination of drugs that may be the answer to triple-negative breast cancer.
The Swiss drugmaker has clearly noticed the genomic profiling group’s ability to personalise cancer care, now that it will take complete ownership of the company.
Researchers have identified a new subtype of prostate cancer that occurs in about 7% of patients with advanced disease. This subset of tumours was responsive to immunotherapy treatment.
Digital health devices have become invaluable tools for improving human health. However, could a pill carrying an inbuilt sensor dehumanize patients, reducing them to a digital readout?
A team of researchers have invented a new cell identification and sorting system that combines a novel imaging technique with artificial intelligence, to identify and sort cells with unprecedented high-throughput speed.
Scientists are now genetically engineering monkeys using CRISPR in an attempt to understand how autism affects the brain.
A new approach to killing C. difficile that silences key bacterial genes while sparing other bacteria may provide a new way to treat the most common hospital-acquired bacterial infection in the US.
Researches have identified molecular features of testicular germ cell cancers that could inform future efforts to improve treatment decisions and help monitor patients to see if their cancer has come back.